Genetics of Pheochromocytoma and Paraganglioma in Spanish Patients
Alberto Cascón(Spanish National Cancer Research Centre), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Anne‐Paule Gimenez‐Roqueplo(Délégation Paris 5), Ana Velasco(Instituto de Investigación Biomédica de Lleida), Guillermo Pita(Spanish National Cancer Research Centre), Elena López‐Jiménez(Spanish National Cancer Research Centre), Cristina Rodríguez‐Antona(Instituto de Salud Carlos III), Iñigo Landa(Inserm), Rocío Letón, Anna González‐Neira(Spanish National Cancer Research Centre), Emilio López-Vidriero(Hospital General Universitario Gregorio Marañón), José Ángel Díaz(Hospital Clínico San Carlos), Xavier Matías‐Guiu(Universitat de Lleida), Nelly Burnichon(Inserm), Cristina Montero‐Conde(Spanish National Cancer Research Centre), Susanna Leskelä(Spanish National Cancer Research Centre), Luis J. Leandro‐García(Spanish National Cancer Research Centre)
Cited by 132
Related Papers
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
|Nature Genetics|2013|1.1k
<scp>FIGO</scp> staging of endometrial cancer: 2023
|International Journal of Gynecology & Obstetrics|2023|926
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
|Cancer Cell|2013|772